Having access to new innovative depression medications is crucial, yet a ground-breaking national report card issued by the coalition of Canadians for Equitable Access to Depression Medications (CEADM) highlights the huge access gap for millions of Canadians.

To read the full report, please visit: http://www.ceadm.ca/national-report-card-parts-1-3/.